Tema 4.5. Vacunación frente a neumococo

Página 18 de 20 MSD© es una marca registrada de Merck Sharp & Dohme Corp., una subsidiaria de Merck & Co., Inc., Kenilworth, NJ. USA. Copyright© 2017 Todos los derechos reservados. Merck Sharp & Dohme de España, S.A. C/ Josefa Valcárcel, 38. 28027 -Madrid 12. Pelton SI, Shea KM, Weycker D, Farkouh RA, Strutton DR, Edelsberg J. Rethinking risk for pneumococcal disease in adults: the role of risk stacking. Open Forum Infect Dis. 2015;2:ofv020. 13. Instituto Nacional de Estadística. Proyecciones de población a largo plazo, 2012-2052. 2016. 14. Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL, Andreo F, et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PloS one. 2013;8(4):e60273. 15. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet (London, England). 2011;377(9773):1264-75. 16. Klugman KP, Chien YW, Madhi SA. Pneumococcal pneumonia and influenza: a deadly combination. Vaccine. 2009;27 Suppl 3:C9-c14. 17. Redondo E; Rivero I; Vargas DA. et al. Vacunación frente a la neumonía adquirida en la comunidad del adulto. Posicionamiento del grupo Neumoexpertos en Prevención. Semergen 2016;42(7):464-475. 18. Ficha técnica de Pneumovax 23. 19. Redondo E. et al. Recomendaciones Semergen en vacunación en el adulto. Ed. Medical and Marketing Comunications. 2013.pp :22-24. ISBN 978-84-695- 8088-2. 20. Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. The Cochrane database of systematic reviews. 2013(1):Cd000422. 21. Diao WQ; Shen N, Yu PX, et al. Efficacy of 23 valent pneumococcal polisaccharyde vaccine in preventing community acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials. Vaccine 2016 34 (13), 1496-503. 22. Andrews RM; Waigth PA; George RC et al. Impact and effectivenes of 23 pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the eldery in England and Wales. Vaccine 2012; 30-6802-8. 23. Ficha Técnica Prevenar 13. 24. Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. The New England journal of medicine. 2015;372(12):1114-25. 25. Joint Committee on Vaccination and Inmunisation, Minute of the meeting 1-02-2017.